Sandra Levy
ARTICLES BY THIS AUTHOR
- 3/8/2021
NACDS' Anderson discusses INFORM Consumers Act in op-ed
In a Morning Consult op-ed, Steve Anderson, president and CEO of the National Association of Chain Drug Stores, welcomed the reintroduction of The INFORM Consumers Act and called on Congress to keep customers safe from organized retail crime. - 3/8/2021
CVS Health releases Health Trends Report 2021
CVS Health president and CEO Karen Lynch noted that a year of transformational challenges has sparked change and innovation in health care. - 3/8/2021
ANI inks $163.5M deal to acquire Novitium Pharma
ANI's acquisition of New Jersey-based Novitium for $163.5 million will strengthen its generics business and diversify its portfolio, according to the company. - 3/7/2021
Viatris, Kindeva Drug Delivery earn tentative nod for generic Symbicort
With tentative approval from the Food and Drug Administration, Viatris faces a legal battle to bring the generic to market and has not planned for any revenue from the product for 2021. - 3/7/2021
Schnuck Markets donated $200K to the Urban League during Black History Month
Schnuck Markets raised funds for the Urban League of Metropolitan St. Louis via a Round Up at the Register campaign in honor of Black History Month. - 3/7/2021
Cardinal Health, eMed distribute at-home COVID-19 tests to thousands of pharmacies
Cardinal Health will distribute eMed-virtually guided and verified tests to pharmacies in the continental United States, Puerto Rico and U.S. Virgin Islands. - 3/7/2021
Breckenridge gets FDA nod for 2 generics
The Afinitor brand and its generic versions had a market value of $712 million, while Saphris had a market value of $233 million, during the 12 months ended December 2020. - 3/7/2021
Kite wins FDA OK for new indication for Yescarta
Kite’s Yescarta is the first CAR T-cell therapy approved for indolent follicular lymphoma. - 3/4/2021
Mayne Pharma launches generic Ortho-Cept
Mayne Pharma launched four generic contraceptive products this year. They have a combined market value of approximately $315 million for the 12 months ended January 2021, according to IQVIA. - 3/4/2021
FDA approves expanded indication for Flucelvax Quadrivalent flu vaccine
Seqirus’ Flucelvax Quadrivalent influenza vaccine is now approved for use in patients age 2 years old and older.
